Extracellular Matrix and Fibroblast Activation in Lymphangioleiomyomatosis
Alexander R. Mukhitov(University of Pennsylvania), Vera P. Krymskaya(University of Pennsylvania), Yan Tang(Brigham and Women's Hospital), Edward Cantu(Hospital of the University of Pennsylvania), Jilly F. Evans(Merck & Co., Inc., Rahway, NJ, USA (United States)), Tiegang Han(Brigham and Women's Hospital), Maria C. Basil(Boston University), Elizabeth P. Henske(Brigham and Women's Hospital), Susan M. Lin(Hospital of the University of Pennsylvania), Kseniya Obraztsova(Lung Institute), O. Ledwell(Pulmonary and Allergy Associates), Ryan W. Rue(University of Pennsylvania)
Cited by 1
Related Papers
Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)
|Cell|1996|2.4k
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|860
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
|Nature reviews. Immunology|2015|758
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686